モノクローナル抗体による癌治療  [in Japanese] Development of cancer therapy using antibodies.:Development of cancer therapy using antibodies  [in Japanese]

Access this Article

Search this Article

Author(s)

    • 山口 俊晴 YAMAGUCHI Toshiharu
    • 財団法人癌研究会付属病院消化器外科 Department of Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research

Abstract

The historical aspects of the development of cancer therapy using antibodies were considered. And cancer treatment trials using antibody conducted in USA were introduced. At present the key antibody in the treatment of cancers is herceptin that bound to HER-2/neu. Many kinds of chemotherapeutic regimen had been combined with antibody therapy. Also some unique antibodies other than herceptin had been developed and clinical studies were conducted. The number of clinical study using antibody in Japan is still very small.

Journal

  • Drug Delivery System

    Drug Delivery System 17(1), 29-34, 2002-01-10

    THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM

References:  12

Cited by:  1

Codes

  • NII Article ID (NAID)
    10008131998
  • NII NACSIS-CAT ID (NCID)
    AN10084591
  • Text Lang
    JPN
  • Article Type
    Journal Article
  • ISSN
    09135006
  • Data Source
    CJP  CJPref  J-STAGE 
Page Top